IBM

Not Yet for Watson

Stat News reports that IBM's Watson for Oncology isn't yet living up to its promise.

The newly announced Microbiome Immunity Project seeks to discover links between autoimmune diseases and bacteria in and on the human body.

The collaboration will place T1D in the field of precision medicine, potentially allowing JDRF to identify factors that potentially lead to T1D.

New York Genome Center, Rockefeller University, and IBM researchers combined whole-genome sequencing with Watson to analyze a glioblastoma sample.

Through the alliance, Cornell has joined the Consortium for Sequencing the Food Supply Chain, an initiative launched by IBM and Mars in early 2015.

Baheal will be the primary channel partner in China for IBM's Watson for Genomics data analytics platform.

MLL will be the first European user of Illumina's new high-throughput sequencing platform, the NovaSeq. 

The collaborations aim to combine Illumina's sequencing systems with Philips' IntelliSpace Genomics platform and with IBM's Watson for Genomics, respectively.

Pfizer will become the first firm to customize IBM's Watson for Drug Development, combining its proprietary data with licensed and publicly available data.

De-identified data from the study, which will look at 10,000 samples by whole-exome sequencing, will be made available for general research use.

Pages

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.